13D Filing: Aisling Capital II LP and Adma Biologics Inc. (ADMA)

Page 12 of 12

Page 12 of 12 – SEC Filing

CUSIP No.  000899 104
SCHEDULE 13D
Page 12 of 12
SIGNATURE
   After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
   Date:     November 16, 2017
AISLING CAPITAL II, LP
By:
Aisling Capital Partners, LP
General Partner
By:
Aisling Capital Partners LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title:   Managing Member
AISLING CAPITAL PARTNERS, LP
By:
Aisling Capital Partners LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title:   Managing Member
AISLING CAPITAL PARTNERS LLC
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title:   Managing Member
/s/ Steve Elms
Steve Elms
/s/ Dennis Purcell
Dennis Purcell
/s/ Andrew Schiff
Andrew Schiff
Attention.  Intentional  misstatements  or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Adma Biologics Inc. (NASDAQ:ADMA)

Page 12 of 12